| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L15 USP17L8 USP17L13 USP17L18 | 2.51e-26 | 114 | 78 | 19 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L15 USP17L8 USP17L13 USP17L18 | 1.38e-25 | 124 | 78 | 19 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L15 USP17L8 USP17L13 USP17L18 | 1.02e-24 | 137 | 78 | 19 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L15 USP17L8 USP17L13 USP17L18 | 7.85e-22 | 192 | 78 | 19 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | HGF USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X F10 USP17L15 ADAMTSL2 USP17L8 USP17L13 USP17L18 | 3.88e-15 | 654 | 78 | 22 | GO:0008233 |
| GeneOntologyMolecularFunction | pre-mRNA 3'-splice site binding | ZRSR2P1 ZRSR2 | 3.12e-04 | 7 | 78 | 2 | GO:0030628 |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L15 USP17L8 USP17L13 USP17L18 | 5.09e-26 | 125 | 76 | 19 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L15 USP17L8 USP17L13 USP17L18 | 8.68e-25 | 144 | 76 | 19 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L21 USP17L4 AMER1 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 PHRF1 USP17L3 USP17L5 USP17L10 USP17L19 MDM2 USP17L22 USP27X USP17L15 USP17L8 USP17L13 USP17L18 | 6.86e-12 | 1009 | 76 | 22 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L21 USP17L4 AMER1 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 PHRF1 USP17L3 USP17L5 USP17L10 USP17L19 MDM2 USP17L22 USP27X USP17L15 USP17L8 USP17L13 USP17L18 | 2.32e-11 | 1074 | 76 | 22 | GO:0043687 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L21 ESYT2 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 ATP10A USP17L15 USP17L8 USP17L13 USP17L18 | 1.55e-07 | 1293 | 77 | 19 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L21 ESYT2 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 ATP10A USP17L15 USP17L8 USP17L13 USP17L18 | 1.66e-07 | 1299 | 77 | 19 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L21 ESYT2 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 ATP10A USP17L15 USP17L8 USP17L13 USP17L18 | 2.31e-07 | 1327 | 77 | 19 | GO:0042175 |
| GeneOntologyCellularComponent | U2AF complex | ZRSR2P1 ZRSR2 | 2.78e-04 | 7 | 77 | 2 | GO:0089701 |
| MousePheno | increased trophectoderm apoptosis | USP17L2 USP17L15 USP17L13 | 2.38e-06 | 8 | 50 | 3 | MP:0012119 |
| MousePheno | abnormal thymus weight | USP17L2 MDM2 USP17L15 USP17L13 | 6.09e-05 | 60 | 50 | 4 | MP:0004954 |
| MousePheno | increased thymus weight | USP17L2 USP17L15 USP17L13 | 8.27e-05 | 24 | 50 | 3 | MP:0004955 |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L2 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 1.57e-29 | 16 | 76 | 13 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L2 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L19 USP17L22 USP17L13 USP17L18 | 1.57e-29 | 16 | 76 | 13 | IPR006861 |
| Domain | UCH | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L8 USP17L13 USP17L18 | 2.81e-28 | 71 | 76 | 18 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L8 USP17L13 USP17L18 | 2.81e-28 | 71 | 76 | 18 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L8 USP17L13 USP17L18 | 3.74e-28 | 72 | 76 | 18 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L8 USP17L13 USP17L18 | 3.74e-28 | 72 | 76 | 18 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L8 USP17L13 USP17L18 | 3.74e-28 | 72 | 76 | 18 | IPR001394 |
| Domain | USP_CS | USP17L21 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L8 USP17L13 USP17L18 | 7.27e-27 | 66 | 76 | 17 | IPR018200 |
| Domain | USP_1 | USP17L21 USP17L4 USP17L2 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP27X USP17L8 USP17L13 USP17L18 | 2.25e-26 | 70 | 76 | 17 | PS00972 |
| Domain | U2AF_small | ZRSR2P1 ZRSR2 | 1.62e-04 | 5 | 76 | 2 | IPR009145 |
| Domain | Znf_FYVE_PHD | KMT2D PCLO PHRF1 KDM4A SP110 | 3.33e-04 | 147 | 76 | 5 | IPR011011 |
| Domain | PHD | KMT2D PHRF1 KDM4A SP110 | 4.76e-04 | 89 | 76 | 4 | SM00249 |
| Domain | Znf_PHD | KMT2D PHRF1 KDM4A SP110 | 5.18e-04 | 91 | 76 | 4 | IPR001965 |
| Domain | ZF_PHD_2 | KMT2D PHRF1 KDM4A SP110 | 6.09e-04 | 95 | 76 | 4 | PS50016 |
| Domain | ZF_PHD_1 | KMT2D PHRF1 KDM4A SP110 | 6.34e-04 | 96 | 76 | 4 | PS01359 |
| Domain | Cyclophilin-type_PPIase_CS | PPIG NKTR | 2.67e-03 | 19 | 76 | 2 | IPR020892 |
| Domain | Cyclophilin-type_PPIase | PPIG NKTR | 3.26e-03 | 21 | 76 | 2 | IPR024936 |
| Domain | PHD | KMT2D PHRF1 SP110 | 3.54e-03 | 75 | 76 | 3 | PF00628 |
| Domain | EPHD | KMT2D KDM4A | 3.58e-03 | 22 | 76 | 2 | PS51805 |
| Domain | Cyclophilin-like_dom | PPIG NKTR | 3.58e-03 | 22 | 76 | 2 | IPR029000 |
| Domain | CSA_PPIASE_2 | PPIG NKTR | 3.58e-03 | 22 | 76 | 2 | PS50072 |
| Domain | Pro_isomerase | PPIG NKTR | 3.58e-03 | 22 | 76 | 2 | PF00160 |
| Domain | - | PPIG NKTR | 3.58e-03 | 22 | 76 | 2 | 2.40.100.10 |
| Domain | Cyclophilin-type_PPIase_dom | PPIG NKTR | 3.58e-03 | 22 | 76 | 2 | IPR002130 |
| Domain | CSA_PPIASE_1 | PPIG NKTR | 3.58e-03 | 22 | 76 | 2 | PS00170 |
| Domain | RRM_dom_euk | ZRSR2 RBM39 | 3.91e-03 | 23 | 76 | 2 | IPR003954 |
| Domain | RRM_1 | ZRSR2 RBM39 | 3.91e-03 | 23 | 76 | 2 | SM00361 |
| Domain | Znf_PHD-finger | KMT2D PHRF1 SP110 | 4.10e-03 | 79 | 76 | 3 | IPR019787 |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 2.96e-30 | 45 | 59 | 17 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 MDM2 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.89e-20 | 221 | 59 | 19 | M27578 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 MDM2 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 4.19e-20 | 191 | 59 | 18 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 MDM2 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.88e-18 | 299 | 59 | 19 | M27574 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 MDM2 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.28e-17 | 262 | 59 | 18 | MM15286 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | HGF USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 RAPGEF2 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.87e-17 | 318 | 59 | 19 | MM15278 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L4 AMER1 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 MDM2 USP17L22 F10 USP17L15 ADAMTSL2 USP17L8 USP17L13 USP17L18 | 4.55e-08 | 1475 | 59 | 22 | M19806 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 MDM2 USP17L22 F10 USP17L15 ADAMTSL2 USP17L8 USP17L13 USP17L18 | 4.21e-07 | 1389 | 59 | 20 | MM15307 |
| Pubmed | Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion. | USP17L21 ZRSR2P1 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 ZRSR2 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.10e-44 | 29 | 79 | 19 | 32527007 |
| Pubmed | Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 SP110 USP17L15 USP17L8 USP17L13 USP17L18 | 4.92e-43 | 26 | 79 | 18 | 35816173 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.06e-42 | 21 | 79 | 17 | 8622927 |
| Pubmed | DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.06e-42 | 21 | 79 | 17 | 14583620 |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.06e-42 | 21 | 79 | 17 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.06e-42 | 21 | 79 | 17 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.06e-42 | 21 | 79 | 17 | 12447969 |
| Pubmed | DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.06e-42 | 21 | 79 | 17 | 18980247 |
| Pubmed | JAK2 is required for induction of the murine DUB-1 gene. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 4.68e-42 | 22 | 79 | 17 | 9154835 |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.13e-41 | 24 | 79 | 17 | 8995226 |
| Pubmed | Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.91e-40 | 25 | 79 | 17 | 21115691 |
| Pubmed | Cdc25A and Dub3 in a high-stakes balancing act. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 3.23e-40 | 33 | 79 | 18 | 20228807 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.85e-40 | 34 | 79 | 18 | 20403174 |
| Pubmed | Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.85e-40 | 34 | 79 | 18 | 17109758 |
| Pubmed | The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.85e-40 | 34 | 79 | 18 | 20388806 |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.85e-40 | 34 | 79 | 18 | 14699124 |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.85e-40 | 34 | 79 | 18 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.85e-40 | 34 | 79 | 18 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.85e-40 | 34 | 79 | 18 | 20368735 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.85e-40 | 34 | 79 | 18 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.85e-40 | 34 | 79 | 18 | 19188362 |
| Pubmed | Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.85e-40 | 34 | 79 | 18 | 11941478 |
| Pubmed | The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.85e-40 | 34 | 79 | 18 | 10936051 |
| Pubmed | The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 6.85e-40 | 34 | 79 | 18 | 21448158 |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.41e-39 | 35 | 79 | 18 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.41e-39 | 35 | 79 | 18 | 21239494 |
| Pubmed | The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 2.81e-39 | 36 | 79 | 18 | 20147298 |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.47e-39 | 37 | 79 | 18 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 SP110 USP17L15 USP17L8 USP17L13 USP17L18 | 5.47e-36 | 50 | 79 | 18 | 31806660 |
| Pubmed | USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities. | ANKRD31 USP17L21 ZRSR2P1 USP17L4 CFAP91 KMT2D AMER1 USP17L2 USP17L12 USP17L1 USP17L17 ZRSR2 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 VSTM5 USP17L22 USP17L15 PREX2 USP17L8 USP17L13 USP17L18 | 9.21e-24 | 674 | 79 | 25 | 37196079 |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | USP17L4 USP17L2 USP17L1 USP17L3 USP17L15 USP17L8 | 2.36e-14 | 10 | 79 | 6 | 24207026 |
| Pubmed | Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells. | USP17L4 USP17L2 USP17L1 USP17L3 USP17L15 USP17L8 | 1.03e-13 | 12 | 79 | 6 | 24695638 |
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | USP17L4 USP17L2 USP17L1 USP17L3 USP17L15 USP17L8 | 3.35e-13 | 14 | 79 | 6 | 11793228 |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | USP17L4 USP17L2 USP17L1 USP17L3 USP17L15 USP17L8 | 3.00e-12 | 19 | 79 | 6 | 28067227 |
| Pubmed | Human and mouse proteases: a comparative genomic approach. | USP17L4 USP17L2 USP17L1 USP17L3 USP27X USP17L15 USP17L8 | 7.22e-10 | 81 | 79 | 7 | 12838346 |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L19 USP17L18 | 1.09e-08 | 119 | 79 | 7 | 28625976 |
| Pubmed | Embryonic demise caused by targeted disruption of a cysteine protease Dub-2. | USP17L2 USP17L15 USP17L13 | 4.50e-08 | 4 | 79 | 3 | 22984479 |
| Pubmed | DNA sequence and analysis of human chromosome 8. | USP17L4 USP17L1 USP17L3 USP17L8 | 4.45e-06 | 48 | 79 | 4 | 16421571 |
| Pubmed | ZRSR1 co-operates with ZRSR2 in regulating splicing of U12-type introns in murine hematopoietic cells. | ZRSR2P1 ZRSR2 | 5.09e-06 | 2 | 79 | 2 | 33691379 |
| Pubmed | Zrsr2 and functional U12-dependent spliceosome are necessary for follicular development. | ZRSR2P1 ZRSR2 | 5.09e-06 | 2 | 79 | 2 | 35198906 |
| Pubmed | RS cyclophilins: identification of an NK-TR1-related cyclophilin. | PPIG CLK1 | 5.09e-06 | 2 | 79 | 2 | 8973360 |
| Pubmed | Multiple roles of beta-catenin in controlling the neurogenic niche for midbrain dopamine neurons. | PITX3 CTNNA1 PCNT | 1.25e-05 | 20 | 79 | 3 | 19439492 |
| Pubmed | Isolation and mapping of human homologues of an imprinted mouse gene U2af1-rs1. | ZRSR2P1 ZRSR2 | 1.53e-05 | 3 | 79 | 2 | 8586425 |
| Pubmed | Concurrent Zrsr2 mutation and Tet2 loss promote myelodysplastic neoplasm in mice. | ZRSR2P1 ZRSR2 | 1.53e-05 | 3 | 79 | 2 | 36030305 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | PPIG AMER1 CLK1 CDK12 CDH23 ATP10A RBM39 | 1.87e-05 | 361 | 79 | 7 | 26167880 |
| Pubmed | Mouse U2af1-rs1 is a neomorphic imprinted gene. | ZRSR2P1 ZRSR2 | 3.05e-05 | 4 | 79 | 2 | 9001233 |
| Pubmed | Cloning and mapping of the U2af1-rs2 gene with a high transmission distortion in interspecific backcross progeny. | ZRSR2P1 ZRSR2 | 3.05e-05 | 4 | 79 | 2 | 7558001 |
| Pubmed | Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition. | ZRSR2P1 ZRSR2 | 7.60e-05 | 6 | 79 | 2 | 33846634 |
| Pubmed | SCFFBXO22 targets HDM2 for degradation and modulates breast cancer cell invasion and metastasis. | KDM4A MDM2 | 7.60e-05 | 6 | 79 | 2 | 31138683 |
| Pubmed | Large-scale identification of mammalian proteins localized to nuclear sub-compartments. | ZRSR2P1 ZRSR2 PCNT | 8.99e-05 | 38 | 79 | 3 | 11555636 |
| Pubmed | A protein related to splicing factor U2AF35 that interacts with U2AF65 and SR proteins in splicing of pre-mRNA. | ZRSR2P1 ZRSR2 | 1.06e-04 | 7 | 79 | 2 | 9237760 |
| Pubmed | Allelic variants between mouse substrains BALB/cJ and BALB/cByJ influence mononuclear cardiomyocyte composition and cardiomyocyte nuclear ploidy. | ZRSR2P1 ZRSR2 | 1.41e-04 | 8 | 79 | 2 | 32371981 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP2 PPIG ESYT2 RPL36 KMT2D PHRF1 GPATCH4 NKTR SP110 RBM39 PRDM2 | 1.61e-04 | 1294 | 79 | 11 | 30804502 |
| Pubmed | SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18. | ZRSR2P1 PPIG KMT2D CDK12 PCNT | 2.74e-04 | 251 | 79 | 5 | 31076518 |
| Pubmed | New nomenclature for chromatin-modifying enzymes. | KMT2D KDM4A PRDM2 | 3.02e-04 | 57 | 79 | 3 | 18022353 |
| Pubmed | Telophase correction refines division orientation in stratified epithelia. | CTNNA1 PCNT | 3.31e-04 | 12 | 79 | 2 | 31833472 |
| Pubmed | Divergent regulation of functionally distinct γ-tubulin complexes during differentiation. | CTNNA1 PCNT | 3.31e-04 | 12 | 79 | 2 | 27298324 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PPIG ESYT2 KMT2D CDK12 SVIL PHRF1 CTNNA1 PRDM2 | 3.77e-04 | 774 | 79 | 8 | 15302935 |
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | HGF USP17L21 USP17L12 USP17L19 RBM39 PCNT | 3.91e-04 | 419 | 79 | 6 | 28700943 |
| Pubmed | The microRNA-200 family coordinately regulates cell adhesion and proliferation in hair morphogenesis. | CTNNA1 PCNT | 4.55e-04 | 14 | 79 | 2 | 29602800 |
| Pubmed | Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis. | PPIG CDK12 CAVIN1 NKTR PCNT | 4.90e-04 | 285 | 79 | 5 | 32838362 |
| Pubmed | Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers. | PPIG RPL36 AMER1 BTF3 SVIL ASCC2 GPATCH4 CTNNA1 RSRC2 RBM39 | 5.17e-04 | 1247 | 79 | 10 | 27684187 |
| Pubmed | Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer. | PCLO MDM2 | 5.25e-04 | 15 | 79 | 2 | 31903119 |
| Pubmed | Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases. | PPIG NKTR | 5.25e-04 | 15 | 79 | 2 | 20676357 |
| Pubmed | Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt. | BTF3 CTNNA1 | 5.25e-04 | 15 | 79 | 2 | 15492215 |
| Pubmed | Dephosphorylation of the transcriptional cofactor NACA by the PP1A phosphatase enhances cJUN transcriptional activity and osteoblast differentiation. | BTF3 SVIL | 5.25e-04 | 15 | 79 | 2 | 30948508 |
| Pubmed | Cell-free cotranslation and selection using in vitro virus for high-throughput analysis of protein-protein interactions and complexes. | TRO MDM2 | 5.99e-04 | 16 | 79 | 2 | 15867431 |
| Pubmed | The C. elegans homolog of human panic-disorder risk gene TMEM132D orchestrates neuronal morphogenesis through the WAVE-regulatory complex. | ANKRD31 PCLO SVIL | 6.01e-04 | 72 | 79 | 3 | 33726789 |
| Pubmed | Comparative mapping of the imprinted U2afbpL gene on mouse chromosome 11 and human chromosome 5. | ZRSR2P1 ZRSR2 | 6.78e-04 | 17 | 79 | 2 | 7956352 |
| Pubmed | Screening E3 substrates using a live phage display library. | MDM2 PRDM2 | 6.78e-04 | 17 | 79 | 2 | 24124579 |
| Pubmed | Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. | ZRSR2 PITX3 PCNT | 7.59e-04 | 78 | 79 | 3 | 19204726 |
| Pubmed | alphaE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway. | CTNNA1 PCNT | 8.50e-04 | 19 | 79 | 2 | 16543460 |
| Pubmed | Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis. | KMT2D ASCC2 | 9.43e-04 | 20 | 79 | 2 | 19047629 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | PPIG ESYT2 ZRSR2 CLK1 CDK12 RSRC2 RBM39 | 1.03e-03 | 695 | 79 | 7 | 23602568 |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | KMT2D KDM4A | 1.04e-03 | 21 | 79 | 2 | 27626377 |
| Pubmed | HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | ANKRD36B PPIG RRAGD CDK12 SVIL ASCC2 GPATCH4 CAVIN1 NKTR RSRC2 | 1.07e-03 | 1371 | 79 | 10 | 36244648 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ANKRD36B CLK1 CDK12 SH3PXD2A TTC14 NKTR ANKRD36C USP27X | 1.08e-03 | 910 | 79 | 8 | 36736316 |
| Pubmed | RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease. | PPIG RPL36 CDK12 GPATCH4 NKTR RSRC2 RBM39 | 1.19e-03 | 713 | 79 | 7 | 29802200 |
| Pubmed | Transcriptional Repression of Aerobic Glycolysis by OVOL2 in Breast Cancer. | SVIL CTNNA1 MDM2 | 1.34e-03 | 95 | 79 | 3 | 35896951 |
| Pubmed | Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray. | SP2 SVIL RSRC2 RAPGEF2 MDM2 | 1.59e-03 | 371 | 79 | 5 | 15747579 |
| Pubmed | Dual function of Yap in the regulation of lens progenitor cells and cellular polarity. | CTNNA1 PCNT | 1.60e-03 | 26 | 79 | 2 | 24384391 |
| Pubmed | Epidermal development requires ninein for spindle orientation and cortical microtubule organization. | CTNNA1 PCNT | 1.60e-03 | 26 | 79 | 2 | 30923192 |
| Pubmed | Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones. | ESYT2 CDK12 PPP1R16B PCNT | 1.75e-03 | 225 | 79 | 4 | 12168954 |
| Pubmed | Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. | PCLO ATP10A ADAMTSL2 | 1.79e-03 | 105 | 79 | 3 | 9628581 |
| Pubmed | Novel interactors and a role for supervillin in early cytokinesis. | SH3PXD2A SVIL | 1.85e-03 | 28 | 79 | 2 | 20309963 |
| Pubmed | The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer. | ASCC2 CTNNA1 | 2.13e-03 | 30 | 79 | 2 | 30480076 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | SP2 KMT2D PCLO ZNF518B PRDM2 | 2.16e-03 | 398 | 79 | 5 | 35016035 |
| Pubmed | miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network. | PCLO PITX3 | 2.27e-03 | 31 | 79 | 2 | 37816598 |
| Interaction | SRRM4 interactions | ZRSR2P1 ZRSR2 CLK1 RBM39 | 1.01e-05 | 37 | 74 | 4 | int:SRRM4 |
| Interaction | DHX8 interactions | RPL36 CDK12 PHRF1 TTC14 GPATCH4 NKTR RSRC2 RBM39 | 1.16e-05 | 292 | 74 | 8 | int:DHX8 |
| Interaction | CLK1 interactions | PPIG ZRSR2 CLK1 CDK12 CDH23 ATP10A RBM39 | 1.58e-05 | 219 | 74 | 7 | int:CLK1 |
| Interaction | ZCCHC10 interactions | ANKRD36B PPIG ELOA2 CDK12 CAVIN1 NKTR RBM39 | 2.55e-05 | 236 | 74 | 7 | int:ZCCHC10 |
| Cytoband | 4p16.1 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 ZNF518B USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 6.72e-25 | 79 | 79 | 14 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L12 USP17L17 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 ZNF518B USP17L19 USP17L22 USP17L15 USP17L13 USP17L18 | 2.38e-18 | 222 | 79 | 14 | chr4p16 |
| Cytoband | 8p23.1 | USP17L4 USP17L2 USP17L1 USP17L3 USP17L8 | 7.34e-06 | 154 | 79 | 5 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | USP17L4 USP17L2 USP17L1 USP17L3 USP17L8 | 5.46e-05 | 234 | 79 | 5 | chr8p23 |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | PPIG NKTR | 1.10e-03 | 19 | 47 | 2 | 909 |
| GeneFamily | PHD finger proteins | KMT2D PHRF1 SP110 | 1.65e-03 | 90 | 47 | 3 | 88 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | KMT2D PRDM2 | 3.52e-03 | 34 | 47 | 2 | 487 |
| GeneFamily | Ankyrin repeat domain containing | ANKRD36B ANKRD31 PPP1R16B ANKRD36C | 3.56e-03 | 242 | 47 | 4 | 403 |
| GeneFamily | Zinc fingers CCCH-type | ZRSR2P1 ZRSR2 | 3.73e-03 | 35 | 47 | 2 | 73 |
| GeneFamily | PDZ domain containing | PCLO RAPGEF2 PREX2 | 7.21e-03 | 152 | 47 | 3 | 1220 |
| GeneFamily | Ubiquitin specific peptidases | USP17L2 USP27X | 9.32e-03 | 56 | 47 | 2 | 366 |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | PHRF1 PPP1R16B PREX2 | 1.16e-02 | 181 | 47 | 3 | 694 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.89e-27 | 86 | 78 | 17 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 7.51e-25 | 112 | 78 | 17 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | HGF USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 8.05e-24 | 160 | 78 | 18 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 MDM2 USP17L22 SP110 USP17L15 USP17L8 USP17L13 USP17L18 | 3.80e-14 | 647 | 78 | 19 | MM981 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 TTC16 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 CAVIN1 USP17L19 MDM2 USP17L22 USP27X SP110 USP17L15 USP17L8 USP17L13 USP17L18 | 5.26e-12 | 1226 | 78 | 22 | MM979 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L21 USP17L4 ELOA2 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L3 USP17L5 USP17L10 USP17L19 MDM2 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 2.44e-10 | 1072 | 78 | 19 | MM1031 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 ASCC2 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.05e-08 | 1198 | 78 | 18 | MM1062 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | CLK1 CDK12 PPP1R16B NKTR RSRC2 RAPGEF2 RBM39 PRDM2 | 4.37e-05 | 432 | 78 | 8 | M41149 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ZRSR2 CDK12 PCLO TTC14 GPATCH4 ZNF518B RSRC2 PREX2 PCNT | 1.98e-05 | 532 | 61 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | PPIG ZRSR2 GPATCH4 NKTR ANKRD36C RSRC2 RBM39 | 3.21e-08 | 197 | 72 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | ANKRD36B ESYT2 CLK1 NKTR ANKRD36C RBM39 | 6.90e-07 | 192 | 72 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | CLK1 NKTR RSRC2 SP110 RBM39 PRDM2 | 8.76e-07 | 200 | 72 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | KMT2D TTC14 NKTR ANKRD36C RBM39 | 4.08e-06 | 147 | 72 | 5 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RPL36 CLK1 PPP1R16B RSRC2 RBM39 | 1.15e-05 | 182 | 72 | 5 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RPL36 CLK1 PPP1R16B RSRC2 RBM39 | 1.18e-05 | 183 | 72 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RPL36 CLK1 PPP1R16B RSRC2 RBM39 | 1.18e-05 | 183 | 72 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PPIG CLK1 CDK12 RSRC2 RBM39 | 1.31e-05 | 187 | 72 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | NKTR ANKRD36C RAPGEF2 RBM39 PRDM2 | 1.35e-05 | 188 | 72 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PPIG RPL36 CDK12 RSRC2 RBM39 | 1.35e-05 | 188 | 72 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | CLK1 NKTR RSRC2 RBM39 PRDM2 | 1.45e-05 | 191 | 72 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | HGF COL24A1 RPL36 BTF3 SPHKAP | 1.57e-05 | 194 | 72 | 5 | 28c5482da199bcee9e85258a88af453d9fdbd56a |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CDK12 TTC14 RSRC2 PREX2 PRDM2 | 1.57e-05 | 194 | 72 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | ANKRD36B TTC14 NKTR ANKRD36C ATP10A | 1.61e-05 | 195 | 72 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | HGF COL24A1 RPL36 BTF3 SPHKAP | 1.73e-05 | 198 | 72 | 5 | 89e25687b614525548279e5fa293c66f5c4abec3 |
| ToppCell | Healthy_donor|World / disease group, cell group and cell class (v2) | RPL36 BTF3 TTC14 NKTR RBM39 | 1.73e-05 | 198 | 72 | 5 | 1ed0b50c9754727a05c27b21f3546bf2e37eef7f |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | CLK1 TTC14 NKTR ANKRD36C RBM39 | 1.77e-05 | 199 | 72 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | Healthy/Control|World / Disease group and Cell class | RPL36 BTF3 TTC14 NKTR RBM39 | 1.77e-05 | 199 | 72 | 5 | 2623c42b3e79e401a485879b52e8bbcbc581544d |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | ANKRD36B ZRSR2 NKTR ANKRD36C SP110 | 1.77e-05 | 199 | 72 | 5 | 952fac67588ad5676f5939e3c7f8bac803c27064 |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 5.73e-36 | 46 | 75 | 18 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L4 KMT2D USP17L2 USP17L12 USP17L1 USP17L17 USP17L20 USP17L11 USP17L24 USP17L3 USP17L5 USP17L10 USP17L19 USP17L22 USP17L15 USP17L8 USP17L13 USP17L18 | 1.75e-34 | 69 | 75 | 19 | DOID:1682 (implicated_via_orthology) |
| Disease | meningioma (is_marker_for) | HGF KMT2D | 1.91e-05 | 3 | 75 | 2 | DOID:3565 (is_marker_for) |
| Disease | biliary tract benign neoplasm (is_marker_for) | HGF MDM2 | 1.33e-04 | 7 | 75 | 2 | DOID:0050625 (is_marker_for) |
| Disease | Microphthalmos | KMT2D PITX3 | 3.45e-04 | 11 | 75 | 2 | C0026010 |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | PCLO CDH23 | 1.06e-03 | 19 | 75 | 2 | EFO_0007044, EFO_0020106 |
| Disease | Hematopoetic Myelodysplasia | ZRSR2 CTNNA1 | 2.48e-03 | 29 | 75 | 2 | C2713368 |